Multipurposing CARs: Same engine, different vehicles

T cells genetically engineered to recognize and eliminate tumor cells through synthetic chimeric antigen receptors (CARs) have demonstrated remarkable clinical efficacy against B cell leukemia over the past decade. This therapy is a form of highly personalized medicine that involves genetically modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossian, A.K.M. Nawshad, Hackett, Christopher S., Brentjens, Renier J., Rafiq, Sarwish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077369/
https://www.ncbi.nlm.nih.gov/pubmed/35151842
http://dx.doi.org/10.1016/j.ymthe.2022.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077369/
https://www.ncbi.nlm.nih.gov/pubmed/35151842
http://dx.doi.org/10.1016/j.ymthe.2022.02.012

Ejemplares similares